JP2003512419A5 - - Google Patents

Download PDF

Info

Publication number
JP2003512419A5
JP2003512419A5 JP2001532747A JP2001532747A JP2003512419A5 JP 2003512419 A5 JP2003512419 A5 JP 2003512419A5 JP 2001532747 A JP2001532747 A JP 2001532747A JP 2001532747 A JP2001532747 A JP 2001532747A JP 2003512419 A5 JP2003512419 A5 JP 2003512419A5
Authority
JP
Japan
Prior art keywords
medicament
manufacture
use according
treatment
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2001532747A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003512419A (ja
Filing date
Publication date
Priority claimed from DE19951701A external-priority patent/DE19951701A1/de
Application filed filed Critical
Publication of JP2003512419A publication Critical patent/JP2003512419A/ja
Publication of JP2003512419A5 publication Critical patent/JP2003512419A5/ja
Abandoned legal-status Critical Current

Links

JP2001532747A 1999-10-27 2000-10-14 虚血状態によって起こる疾患の治療または予防用医薬の製造のための2−イミダゾリル置換カルビノールの使用 Abandoned JP2003512419A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19951701.0 1999-10-27
DE19951701A DE19951701A1 (de) 1999-10-27 1999-10-27 Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
PCT/EP2000/010126 WO2001030327A2 (de) 1999-10-27 2000-10-14 Verwendung von 2-imidazolyl-substituierten carbinolen zur herstellung eines medikaments zur behandlung oder prophylaxe von durch ischämischen zuständen

Publications (2)

Publication Number Publication Date
JP2003512419A JP2003512419A (ja) 2003-04-02
JP2003512419A5 true JP2003512419A5 (enExample) 2007-11-29

Family

ID=7927020

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001532747A Abandoned JP2003512419A (ja) 1999-10-27 2000-10-14 虚血状態によって起こる疾患の治療または予防用医薬の製造のための2−イミダゾリル置換カルビノールの使用

Country Status (30)

Country Link
US (1) US6291502B1 (enExample)
EP (1) EP1227811B1 (enExample)
JP (1) JP2003512419A (enExample)
KR (1) KR20020060213A (enExample)
CN (1) CN1188125C (enExample)
AR (1) AR026241A1 (enExample)
AT (1) ATE257702T1 (enExample)
AU (1) AU778836B2 (enExample)
BR (1) BR0015024A (enExample)
CA (1) CA2388956A1 (enExample)
CZ (1) CZ295925B6 (enExample)
DE (2) DE19951701A1 (enExample)
DK (1) DK1227811T3 (enExample)
EE (1) EE200200218A (enExample)
ES (1) ES2213621T3 (enExample)
HK (1) HK1048938B (enExample)
HR (1) HRP20020362A2 (enExample)
HU (1) HUP0203213A3 (enExample)
IL (1) IL149208A0 (enExample)
NO (1) NO20021909D0 (enExample)
NZ (1) NZ518586A (enExample)
PL (1) PL355911A1 (enExample)
PT (1) PT1227811E (enExample)
RU (1) RU2257205C2 (enExample)
SK (1) SK5512002A3 (enExample)
TR (1) TR200201140T2 (enExample)
TW (1) TWI246424B (enExample)
WO (1) WO2001030327A2 (enExample)
YU (1) YU20902A (enExample)
ZA (1) ZA200203035B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726829B2 (en) * 1997-04-08 2004-04-27 Scimed Life Systems, Inc. Method of manufacturing a stent
EP2292595A1 (en) 2002-01-04 2011-03-09 NeuroSearch AS Potassium channel modulators
AR049847A1 (es) * 2004-07-29 2006-09-06 Merck & Co Inc Inhibidores de los canales de potasio
RU2373934C1 (ru) * 2008-03-19 2009-11-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
US10040767B2 (en) 2014-05-15 2018-08-07 Peloton Therapeutics, Inc. Benzimidazole derivatives and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
BE794940A (fr) * 1972-02-04 1973-08-02 Gist Brocades Nv Nouveaux composes anorexigenes
US4152441A (en) 1972-02-04 1979-05-01 Gist-Brocades N.V. Analgesic imidazolemethanols
US5063220A (en) * 1988-10-21 1991-11-05 Syntex Pharmaceuticals, Ltd. Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US6175013B1 (en) * 1994-06-10 2001-01-16 Eli Lilly And Company Imidazolinyl tachykinin receptor antagonists
DE69717627T2 (de) 1996-06-27 2003-09-18 Janssen Pharmaceutica N.V., Beerse N-4-(heteroarylmethyl)phenyl-heteroarylaminderivate

Similar Documents

Publication Publication Date Title
RU2647467C2 (ru) Новый способ лечения инфаркта миокарда с применением фрагмента hmgb1
JP2019094345A5 (enExample)
JP2002508352A5 (ja) 4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体)
JP2012529486A5 (enExample)
JP2003523927A5 (enExample)
JP2002525323A5 (enExample)
JP2006528685A5 (enExample)
JP2020532547A5 (enExample)
CN1277553A (zh) 血管生成促进剂和血管生成增效剂
JP2005508337A5 (enExample)
JP2003503449A5 (enExample)
JP2006501298A5 (enExample)
JP2007520452A5 (enExample)
JP2011201916A (ja) 光学活性ピリジル−4h−1,2,4−オキサジアジン誘導体およびその血管疾患の治療における使用
JP2011527675A5 (enExample)
KR910005708B1 (ko) 1,5-벤조티아제핀 유도체의 제조방법
JP2005502579A5 (enExample)
JP2008513510A5 (enExample)
JP2001510793A5 (enExample)
JP2003512419A5 (enExample)
HUE027088T2 (en) Use of a combination of a sinusoidal current current inhibitor and an angiotensin converting enzyme inhibitor to treat heart failure with retained systolic function
JP2003508543A5 (enExample)
RU2006135653A (ru) Способы, препятствующие фиброзу
JP2002524460A5 (enExample)
JP2009502770A5 (enExample)